Clinical Trial Update: COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1) [NA]

View source ↗

Summary

This update reports termination of the first-in-man trial evaluating ISA 247 elution to prevent restenosis in patients with coronary artery disease. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• ISA 247 (ISA-247)

Snippet

Sponsor: Atrium Medical Corporation | Conditions: Coronary Artery Disease | NA | Status: TERMINATED